FMP
AMN Healthcare Services, Inc. (NYSE: AMN) Overview and Analyst Insights
May 8, 2025 8:00 PM - Danny Green(Last modified: May 9, 2025 3:50 PM)
Image credit: Google Images
- The consensus price target for AMN Healthcare Services, Inc. (NYSE: AMN) has significantly declined, but Jefferies maintains a positive outlook with a much higher price target.
- Early indicators suggest a potential revenue beat for Q1 2025, supported by less-than-expected decline in contract labor spending by HCA Healthcare.
- Innovative solutions like WorkWise and ShiftWise Flex are expected to drive significant revenue growth, leveraging changes in U.S. demographics and healthcare coverage.
AMN Healthcare Services, Inc. (NYSE: AMN) is a leading provider of healthcare workforce solutions and staffing services in the U.S. The company operates through three main segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. These segments offer services like travel nurse staffing, locum tenens staffing, telehealth, and workforce optimization.
The consensus price target for AMN's stock has seen a significant decline over the past year, dropping from $49.8 to $25. This change reflects a shift in analysts' expectations, possibly due to market conditions or company performance. However, Jefferies has set a much higher price target of $175, indicating a positive outlook for AMN's future.
Despite the drop in the consensus price target, early indicators suggest AMN Healthcare may report a revenue beat for Q1 2025. This potential revenue growth is supported by HCA Healthcare's contract labor spending, which decreased by only 10.5% compared to the anticipated 18% decline. This suggests a possible bottom in the healthcare staffing market.
AMN Healthcare's innovative solutions, such as WorkWise and ShiftWise Flex, are expected to drive significant revenue growth. These solutions enhance operational efficiency and are well-positioned to benefit from changes in U.S. age demographics and an increase in insured individuals. This positions AMN for strong financial performance and supports the higher price target set by Jefferies.
In Q4 2024, AMN Healthcare reported significant sequential revenue growth for the first time in two years, indicating a potential end to its cyclical decline. While acquisitions are paused due to high debt levels, the company's long-term growth drivers, such as platformization and an expanded technology segment, remain strong. This supports the positive outlook and price target set by Jefferies.
Other Blogs
Nov 22, 2024 5:08 AM - Parth Sanghvi
Fundamental Analysis: Principles, Types, and How to Use It
Fundamental analysis is one of the most essential tools for investors and analysts alike, helping them assess the intrinsic value of a stock, company, or even an entire market. It focuses on the financial health and economic position of a company, often using key data such as earnings, expenses, ass...
Dec 17, 2024 8:58 AM - Sanzhi Kobzhan
Examining Tesla’s Financial Health Using FinancialModelingPrep’s Ratios API
Tesla, one of the world’s most talked-about electric vehicle manufacturers, attracts a lot of attention from investors and market watchers. By examining a snapshot of Tesla’s financial ratios—such as those provided by FinancialModelingPrep’s Ratios API—we can get a clearer picture of the company’s f...
Dec 22, 2024 7:59 AM - Sanzhi Kobzhan
Two great Software Platform Stocks Similar to Palantir (PLTR)
When it comes to cutting-edge software and data analytics, Palantir Technologies (NYSE: PLTR) is often front and center. But for many investors, it’s important to consider alternative or complementary stocks in the same sector that may offer robust growth potential. As PLTR looks expensive (overvalu...
